Bin Sun

Bin Sun

Auto-generated profile, based on publicly available information

Bin Sun

MRC Laboratory of Medical Sciences (LMS), London, UK

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
AGAna Guerrero
Ana Guerrero
NHNicolás Herranz
Nicolás Herranz
BSBin Sun
Bin Sun
VWVerena Wagner
Verena Wagner
SGSuchira Gallage
Suchira Gallage
JGJesús Gil
Jesús Gil

8 June 2020 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
RMRicardo Iván Martínez-Zamudio
Ricardo Iván Martínez-Zamudio
PRPierre-François Roux
Pierre-François Roux
JFJosé Américo N.L.F. de Freitas
José Américo N.L.F. de Freitas
LRLucas Robinson
Lucas Robinson
GDGregory Doré
Gregory Doré
OBOliver Bischof
Oliver Bischof

2 August 2016 in Frontiers in Neuroscience
Verified
Journal Article
Open access
ECEun Hyuk Chang
Eun Hyuk Chang
IAIstvan Adorjan
Istvan Adorjan
MMMayara V. Mundim
Mayara V. Mundim
BSBin Sun
Bin Sun
MDMaria L. V. Dizon
Maria L. V. Dizon
FSFrancis Szele
Francis Szele
Traumatic brain injury (TBI) is common in both civilian and military life placing a large burden on survivors and society. However, with recognition of neural stem cells in adult mammals, including humans, came the possibility of harnessing these cells for repair of damaged brain tissue, previously thought to be a lost cause. In this review we focus on the adult subventricular zone (SVZ), an important neurogenic niche within the mature brain in which neural stem cells continue to reside. We review how the SVZ is perturbed following various animal traumatic brain injury models with regards to cell proliferation, emigration, survival and differentiation, and we review specific molecules involved in these processes. Together, this information suggests next steps in attempting to translate knowledge from animal models of TBI into human therapies for TBI.

3 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
IDImanol Duran
Imanol Duran
JPJoaquim Pombo
Joaquim Pombo
BSBin Sun
Bin Sun
SGSuchira Gallage
Suchira Gallage
HKHiromi Kudo
Hiromi Kudo
JGJesús Gil
Jesús Gil
Cellular senescence is a stress response with broad pathophysiological implications. Senotherapies can induce senescence to treat cancer or eliminate senescent cells to ameliorate ageing and age-related pathologies. However, the success of senotherapies is limited by the lack of reliable ways to identify senescence. Here, we use nuclear morphology features of senescent cells to devise machine-learning classifiers that accurately predict senescence induced by diverse stressors in different cell types and tissues. As a proof-of-principle, we use these senescence classifiers to characterise senolytics and to screen for drugs that selectively induce senescence in cancer cells but not normal cells. Moreover, a tissue senescence score served to assess the efficacy of senolytic drugs and identified senescence in mouse models of liver cancer initiation, ageing, and fibrosis, and in patients with fatty liver disease. Thus, senescence classifiers can help to detect pathophysiological senescence and to discover and validate potential senotherapies.

27 November 2023 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
DMDomhnall McHugh
Domhnall McHugh
BSBin Sun
Bin Sun
CGCarmen Gutierrez-Muñoz
Carmen Gutierrez-Muñoz
FHFernanda Hernández-González
Fernanda Hernández-González
MMMassimiliano Mellone
Massimiliano Mellone
JGJesús Gil
Jesús Gil
Drugs that selectively kill senescent cells (senolytics) improve the outcomes of cancer, fibrosis and age-related diseases. Despite their potential, our knowledge of the molecular pathways that affect the survival of senescent cells is limited. To discover senolytic targets, we performed RNAi screens and identified coatomer complex I (COPI) vesicle formation as a liability of senescent cells. Genetic or pharmacological inhibition of COPI results in Golgi dispersal, dysfunctional autophagy, and unfolded protein response-dependent apoptosis of senescent cells, and knockdown of COPI subunits improves the outcomes of cancer and fibrosis in mouse models. Drugs targeting COPI have poor pharmacological properties, but we find that N-myristoyltransferase inhibitors (NMTi) phenocopy COPI inhibition and are potent senolytics. NMTi selectively eliminated senescent cells and improved outcomes in models of cancer and non-alcoholic steatohepatitis. Our results suggest that senescent cells rely on a hyperactive secretory apparatus and that inhibiting trafficking kills senescent cells with the potential to treat various senescence-associated diseases.

16 April 2018 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
IPIoanna Pavlaki
Ioanna Pavlaki
FAFarah Alammari
Farah Alammari
BSBin Sun
Bin Sun
NCNeil Clark
Neil Clark
TSTamara Sirey
Tamara Sirey
KVKeith W Vance
Keith W Vance
Many long non‐coding RNAs (lncRNAs) are expressed during central nervous system (CNS) development, yet their in vivo roles and mechanisms of action remain poorly understood. Paupar , a CNS‐expressed lncRNA, controls neuroblastoma cell growth by binding and modulating the activity of transcriptional regulatory elements in a genome‐wide manner. We show here that the Paupar lncRNA directly binds KAP1, an essential epigenetic regulatory protein, and thereby regulates the expression of shared target genes important for proliferation and neuronal differentiation. Paupar promotes KAP1 chromatin occupancy and H3K9me3 deposition at a subset of distal targets, through the formation of a ribonucleoprotein complex containing Paupar , KAP1 and the PAX6 transcription factor. Paupar ‐KAP1 genome‐wide co‐occupancy reveals a fourfold enrichment of overlap between Paupar and KAP1 bound sequences, the majority of which also appear to associate with PAX6. Furthermore, both Paupar and Kap1 loss‐of‐function in vivo disrupt olfactory bulb neurogenesis. These observations provide important conceptual insights into the trans ‐acting modes of lncRNA‐mediated epigenetic regulation and the mechanisms of KAP1 genomic recruitment, and identify Paupar and Kap1 as regulators of neurogenesis in vivo .